UBS analyst Andrew Spinola lowered the firm’s price target on Viavi (VIAV) to $11 from $11.50 and keeps a Neutral rating on the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VIAV:
- Viavi price target lowered to $11 from $12 at B. Riley
- Optimistic Buy Rating for Viavi Solutions Amid Strong Network Enablement Growth and Strategic Caution
- Viavi Solutions Reports Strong Q3 Fiscal 2025 Growth
- Viavi reports Q3 adjusted EPS 15c, consensus 12c
- Viavi sees Q4 adjusted EPS 10c-13c, consensus 9c
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue